{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T21:43:44Z","timestamp":1776721424254,"version":"3.51.2"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research","doi-asserted-by":"crossref","award":["09\/140(0179)\/2020-EMR-I"],"award-info":[{"award-number":["09\/140(0179)\/2020-EMR-I"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Council of scientific and Industrial research","award":["09\/0140(13153)\/2022-EMR-I"],"award-info":[{"award-number":["09\/0140(13153)\/2022-EMR-I"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s11030-023-10616-8","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T13:02:45Z","timestamp":1677589365000},"page":"97-110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Synthesis and studies of new purines\/pyrimidine derivatives as multi-targeted agents involving various receptor sites in the immune system"],"prefix":"10.1007","volume":"28","author":[{"given":"Gurmeet","family":"Kaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0258-8982","authenticated-orcid":false,"given":"Manisha","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafiz Muzzammel","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"key":"10616_CR1","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783\u2013801. https:\/\/doi.org\/10.1016\/j.cell.2006.02.015","journal-title":"Cell"},{"key":"10616_CR2","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.tcb.2014.11.001","volume":"25","author":"C Hagerling","year":"2015","unstructured":"Hagerling C, Casbon AJ, Werb Z (2015) Balancing the innate immune system in tumor development. Trends Cell Biol 25:214\u2013220. https:\/\/doi.org\/10.1016\/j.tcb.2014.11.001","journal-title":"Trends Cell Biol"},{"key":"10616_CR3","doi-asserted-by":"publisher","first-page":"432","DOI":"10.15761\/ICST.1000183","volume":"3","author":"L Sun","year":"2016","unstructured":"Sun L, Jiang Q, Zhang Y, Liang H, Ren H, Zhang D (2016) Toll-like receptors and breast cancer. Integer Cancer Sci Therap 3:432\u2013436. https:\/\/doi.org\/10.15761\/ICST.1000183","journal-title":"Integer Cancer Sci Therap"},{"key":"10616_CR4","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3389\/fimmu.2014.00224","volume":"5","author":"N Yusuf","year":"2014","unstructured":"Yusuf N (2014) Toll-like receptor mediated regulation of breast cancer: a case of mixed blessings. Front Immunol 5:224. https:\/\/doi.org\/10.3389\/fimmu.2014.00224","journal-title":"Front Immunol"},{"key":"10616_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/716564","volume":"2012","author":"D Bhattacharya","year":"2012","unstructured":"Bhattacharya D, Yusuf N (2012) Expression of Toll-like receptors on breast tumors: taking toll on tumor microenvironment. Int J Breast cancer 2012:1\u20137. https:\/\/doi.org\/10.1155\/2012\/716564","journal-title":"Int J Breast cancer"},{"key":"10616_CR6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3389\/fimmu.2014.00330","volume":"5","author":"J Sandholm","year":"2014","unstructured":"Sandholm J, Salander KS (2014) Toll-like receptor 9 in breast cancer. Front Immunol 5:330. https:\/\/doi.org\/10.3389\/fimmu.2014.00330","journal-title":"Front Immunol"},{"key":"10616_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/sj.onc.1210911","volume":"27","author":"AM Krieg","year":"2008","unstructured":"Krieg AM (2008) Toll-like receptor 9 (TLR9) agonists in the treatment of cancer. Oncogene 27:161\u2013167. https:\/\/doi.org\/10.1038\/sj.onc.1210911","journal-title":"Oncogene"},{"key":"10616_CR8","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1002\/jmv.26826","volume":"93","author":"S Khanmohammadi","year":"2021","unstructured":"Khanmohammadi S, Rezaei N (2021) Role of toll-like receptors in the pathogenesis of COVID-19. J Med Virol 93:2735\u20132739. https:\/\/doi.org\/10.1002\/jmv.26826","journal-title":"J Med Virol"},{"key":"10616_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.601685","author":"GFG Bezemer","year":"2021","unstructured":"Bezemer GFG, Garssen J (2021) TLR9 and COVID-19: A multidisciplinary theory of a multifaceted therapeutic target. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2020.601685","journal-title":"Front Pharmacol"},{"key":"10616_CR10","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jmb.2013.11.024","volume":"426","author":"SN Lester","year":"2014","unstructured":"Lester SN, Li K (2014) Toll-like receptors in antiviral innate immunity. J Mol Biol 426:1246\u20131264. https:\/\/doi.org\/10.1016\/j.jmb.2013.11.024","journal-title":"J Mol Biol"},{"key":"10616_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1365-2249.2010.04196.x","volume":"161","author":"M Carty","year":"2010","unstructured":"Carty M, Bowie AG (2010) Recent insights into the role of toll-like receptors in viral infections. Clin Exp Immunol 161:397\u2013406. https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04196.x","journal-title":"Clin Exp Immunol"},{"key":"10616_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1684\/ecn.2020.0448","volume":"31","author":"H Mojtabavi","year":"2020","unstructured":"Mojtabavi H, Saghazadeh A, Rezaei N (2020) Interleukin-6 and severe COVID-19: a systematic review and meta-analysis. Eur Cytokine Netw 31:44\u201349. https:\/\/doi.org\/10.1684\/ecn.2020.0448","journal-title":"Eur Cytokine Netw"},{"key":"10616_CR13","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1002\/jmv.26123","volume":"92","author":"M Lotfi","year":"2020","unstructured":"Lotfi M, Rezaei N (2020) SARS-CoV-2: a comprehensive review from pathogenicity of the virus to clinical consequences. J Med Virol 92:1864\u20131874. https:\/\/doi.org\/10.1002\/jmv.26123","journal-title":"J Med Virol"},{"key":"10616_CR14","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.jsps.2020.08.024","volume":"28","author":"A Alnefaie","year":"2020","unstructured":"Alnefaie A, Albogami S (2020) Current approaches used in treating COVID-19 from a molecular mechanisms and immune response perspective. Saudi Pharm J 28:1333\u20131352. https:\/\/doi.org\/10.1016\/j.jsps.2020.08.024","journal-title":"Saudi Pharm J"},{"key":"10616_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/14728222.2017.1299128","volume":"21","author":"A Saghazadeh","year":"2017","unstructured":"Saghazadeh A, Rezaei N (2017) Implications of toll-like receptors in Ebola infection. Expert Opin Ther Targets 21:415\u2013425. https:\/\/doi.org\/10.1080\/14728222.2017.1299128","journal-title":"Expert Opin Ther Targets"},{"key":"10616_CR16","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1002\/fsn3.1858","volume":"8","author":"F Babaei","year":"2020","unstructured":"Babaei F, Nassiri-Asi M, Hosseinzadeh H (2020) Curcumin (a constituent of turmeric): new treatment option against COVID-19. Food Sci Nutr 8:5215\u20135227. https:\/\/doi.org\/10.1002\/fsn3.1858","journal-title":"Food Sci Nutr"},{"key":"10616_CR17","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.3390\/molecules24234386","volume":"24","author":"Z Mbese","year":"2019","unstructured":"Mbese Z, Khwaza V, Aderibigbe BA (2019) Curcumin and its derivatives as potential therapeutic agents in prostate, colon and breast cancers. Molecules 24:4386. https:\/\/doi.org\/10.3390\/molecules24234386","journal-title":"Molecules"},{"key":"10616_CR18","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3390\/molecules25030479","volume":"25","author":"DY Lee","year":"2020","unstructured":"Lee DY, Hou YC, Yang JS, Lin HY, Chang TY, Lee KH, Kuo SC, Hsieh MT (2020) Synthesis, anticancer activity, and preliminary pharmacokinetic evaluation of 4,4-disubstituted curcuminoid 2,2-is(hydroxymethyl)propionate derivatives. Molecules 25:479. https:\/\/doi.org\/10.3390\/molecules25030479","journal-title":"Molecules"},{"key":"10616_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/scipharm86020025","volume":"86","author":"PW Prasetyaningrum","year":"2018","unstructured":"Prasetyaningrum PW, Bahtiar A, Hayun H (2018) Synthesis and cytotoxicity evaluation of novel asymmetrical mono-carbonyl analogs of curcumin (AMACs) against Vero, HeLa, and MCF7 cell lines. Sci Pharm 86:25. https:\/\/doi.org\/10.3390\/scipharm86020025","journal-title":"Sci Pharm"},{"key":"10616_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112040","author":"Z Shabaninejad","year":"2020","unstructured":"Shabaninejad Z, Pourhanifeh MH, Movahedpour A, Mottaghi R, Nickdasti A, Mortezapour E, Shafiee A, Hajighadimi S, Moradizarmehri S, Sadeghian M, Mousavi SM, Mirzaei H (2020) Therapeutic potentials of curcumin in the treatment of Glioblstoma. Eur J Med Chem. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112040","journal-title":"Eur J Med Chem"},{"key":"10616_CR21","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1080\/14756366.2018.1488695","volume":"33","author":"BR Kim","year":"2018","unstructured":"Kim BR, Park JY, Jeong HJ, Kwon HJ, Park SJ, Lee IC, Ryu YB, Lee WS (2018) Design, synthesis, and evaluation of curcumin analogues as potential inhibitors of bacterial sialidase. J Enzyme Inhib Med Chem 33:1256\u20131265. https:\/\/doi.org\/10.1080\/14756366.2018.1488695","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10616_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jtcme.2016.05.005","volume":"7","author":"A Amalraj","year":"2017","unstructured":"Amalraj A, Pius A, Gopi S, Gopi S (2017) Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives-a review. J Tradit Complement Med 7:205\u2013233. https:\/\/doi.org\/10.1016\/j.jtcme.2016.05.005","journal-title":"J Tradit Complement Med"},{"key":"10616_CR23","first-page":"3755","volume":"11","author":"G Kaur","year":"2021","unstructured":"Kaur G, Kaur M, Bansal M (2021) Review article new insights of structural activity relationship of curcumin and correlating their efficacy in anticancer studies with some other similar molecules. Am J Cancer Res 11:3755\u20133765","journal-title":"Am J Cancer Res"},{"key":"10616_CR24","doi-asserted-by":"publisher","first-page":"5138","DOI":"10.1080\/07391102.2020.1868338","volume":"40","author":"A Patel","year":"2020","unstructured":"Patel A, Rajendran M, Shah A, Patel H, Pakala SB, Karyala P (2020) Virtual screening of curcumin and its analogs against the spike surface glycoprotein of SARS-CoV-2 and SARS-CoV. J Biomol 40:5138\u20135146. https:\/\/doi.org\/10.1080\/07391102.2020.1868338","journal-title":"J Biomol"},{"key":"10616_CR25","doi-asserted-by":"publisher","first-page":"6701","DOI":"10.1016\/j.bmc.2010.07.063","volume":"18","author":"B Yadav","year":"2010","unstructured":"Yadav B, Taurin S, Rosengren RJ, Schumacher M, Diederich M, Somers-Edgars TJ, Larsen L (2010) Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcumin. Bioorg Med Chem 18:6701\u20136707. https:\/\/doi.org\/10.1016\/j.bmc.2010.07.063","journal-title":"Bioorg Med Chem"},{"key":"10616_CR26","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1021\/jf104402t","volume":"59","author":"BRK Bhawana","year":"2011","unstructured":"Bhawana BRK, Buttar HS, Jain VK, Jain N (2011) Curcumin Nanoparticles: preparation, characterization, and antimicrobial study. J Agric Food Chem 59:2056\u20132061. https:\/\/doi.org\/10.1021\/jf104402t","journal-title":"J Agric Food Chem"},{"key":"10616_CR27","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3390\/ijms20051033","volume":"20","author":"MA Tomeh","year":"2019","unstructured":"Tomeh MA, Hadianamrei R, Zhao X (2019) A review of curcumin and its derivatives as anticancer agents. Int J Mol Sci 20:1033. https:\/\/doi.org\/10.3390\/ijms20051033","journal-title":"Int J Mol Sci"},{"key":"10616_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/ph12040161","volume":"12","author":"PM Bonaccorsi","year":"2019","unstructured":"Bonaccorsi PM, Labbozzetta M, Barattucci A, Salerno TMG, Poma P, Notarbartolo M (2019) Synthesis of curcumin derivatives and analysis of their antitumor effects in triple negative breast cancer (TNBC) cell lines. Pharmaceuticals 12:161. https:\/\/doi.org\/10.3390\/ph12040161","journal-title":"Pharmaceuticals"},{"key":"10616_CR29","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ejmech.2016.01.017","volume":"110","author":"R Wang","year":"2016","unstructured":"Wang R, Zhang X, Chen C, Chen G, Zhong Q, Zhang Q, Zheng S, Wang G, Chen QH (2016) Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based anticancer agents. Eur J Med Chem 110:164\u2013180. https:\/\/doi.org\/10.1016\/j.ejmech.2016.01.017","journal-title":"Eur J Med Chem"},{"key":"10616_CR30","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45:2615\u20132623. https:\/\/doi.org\/10.1021\/jm020017n","journal-title":"J Med Chem"},{"key":"10616_CR31","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","volume":"2","author":"H Pajouhesh","year":"2005","unstructured":"Pajouhesh H, Lenz GR (2005) Medicinal chemical properties of successful central nervous system drugs. NeuroRx 2:541\u2013553. https:\/\/doi.org\/10.1602\/neurorx.2.4.541","journal-title":"NeuroRx"},{"key":"10616_CR32","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1021\/acs.molpharmaceut.6b00031","volume":"13","author":"YY Zhang","year":"2016","unstructured":"Zhang YY, Liu H, Summerfield SG, Luscombe CN, Sahi J (2016) Integrating in silico and in vitro approaches to predict drug accessibility to the central nervous system. Mol Pharmaceutics 13:1540\u20131550. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b00031","journal-title":"Mol Pharmaceutics"},{"key":"10616_CR33","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1021\/jm501535r","volume":"58","author":"Z Rankovic","year":"2015","unstructured":"Rankovic Z (2015) CNS drug design: balancing physicochemical properties for optimal brain exposure. J Med Chem 58:2584\u20132608. https:\/\/doi.org\/10.1021\/jm501535r","journal-title":"J Med Chem"},{"key":"10616_CR34","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3109\/14756366.2015.1069288","volume":"31","author":"AA Abdel-Aziz","year":"2016","unstructured":"Abdel-Aziz AA, El-Azab AS, Alanazi AM, Asiri YA, Al-Suwaidan IA, Maarouf AR, Ayyad RR, Shawer TZ (2016) Synthesis and potential antitumor activity of 7-(4-substituted piperazin-1-yl)-4-oxoquinolines based on ciprofloxacin and norfloxacin scaffolds: in silico studies. J Enzyme Inhib Med Chem 31:796\u2013809. https:\/\/doi.org\/10.3109\/14756366.2015.1069288","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10616_CR35","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.1021\/jo0493875","volume":"69","author":"M Shimizu","year":"2004","unstructured":"Shimizu M, Wada T, Oka N, Saigo K (2004) A novel method for the synthesis of dinucleoside boranophosphates by a boranophosphotriester method. J Org Chem 69:5261\u20135268. https:\/\/doi.org\/10.1021\/jo0493875","journal-title":"J Org Chem"},{"key":"10616_CR36","unstructured":"PubChem CID 115657068. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/N-benzyl-2-_2-oxo-1H-pyrazin-3-yl_amino_acetamide. Accessed 29 Jan 2016"},{"key":"10616_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-019-0738-2","volume":"7","author":"TH Kang","year":"2019","unstructured":"Kang TH, Mao CP, Kim YS, Kim TW, Yang A, Lam B, Tseng SH, Farmer E, Park YM, Hung CF (2019) TLR9 acts as a sensor for tumor-released DNA to modulate anti-tumor immunity after chemotherapy. J Immunother Cancer 7:1\u20138. https:\/\/doi.org\/10.1186\/s40425-019-0738-2","journal-title":"J Immunother Cancer"},{"key":"10616_CR38","doi-asserted-by":"publisher","first-page":"480","DOI":"10.5530\/JYP.2017.9.94","volume":"9","author":"P Rathinasabapathy","year":"2017","unstructured":"Rathinasabapathy P, Subramanian S, Duraisamy K (2017) Comparative in silico docking analysis of curcumin and resveratol on breast cancer proteins and their synergistic effect on MCF-7 cell line. J Young Pharm 9:480\u2013485. https:\/\/doi.org\/10.5530\/JYP.2017.9.94","journal-title":"J Young Pharm"},{"key":"10616_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-015-0422-1","author":"B Hu","year":"2015","unstructured":"Hu B, Ge X, Wang LF, Shi Z (2015) Bat origin of human coroviruses. Virol J. https:\/\/doi.org\/10.1186\/s12985-015-0422-1","journal-title":"Virol J"},{"key":"10616_CR40","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3389\/fmicb.2019.01057","volume":"10","author":"L Velazquez-Salinas","year":"2019","unstructured":"Velazquez-Salinas L, Verdugo-Rodriguez A, Rodriguez LL, Borca MV (2019) The role of interleukin 6 during viral infections. Front Microbiol 10:1057. https:\/\/doi.org\/10.3389\/fmicb.2019.01057","journal-title":"Front Microbiol"},{"key":"10616_CR41","doi-asserted-by":"publisher","unstructured":"Bowers KJ, Chow E, Xu H, Dror RO, Eastwood MP, Gregersen BA, Klepeis JL, Kolossvary I, Moraes MA, Sacerdoti FD, Salmon J, Shan Y, Shaw DE (2006) Molecular dynamics-scalable algorithms for molecular dynamics simulation on commodity clusters. In Proceedings of the SC\u201906: Proceedings of the 2006 ACM\/IEEE Conference Supercomputing, Tampa, FL, USA, 11\u201317 November, 43. doi: https:\/\/doi.org\/10.1109\/SC.2006.54","DOI":"10.1109\/SC.2006.54"},{"key":"10616_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cdc.2022.100851","author":"K El Khatabi","year":"2022","unstructured":"El Khatabi K, El-mernissi R, Moukhliss Y, Hajji H, Rehman HM, Yadav R, Lakhlifi T, Ajana MA, Bouachrine M (2022) Rational design of novel potential EGFR inhibitors by 3D-QSAR, molecular docking, molecular dynamics simulation, and pharmacokinetics studies. Chem Data Collect. https:\/\/doi.org\/10.1016\/j.cdc.2022.100851","journal-title":"Chem Data Collect"},{"key":"10616_CR43","first-page":"474","volume":"1","author":"O James","year":"2009","unstructured":"James O, Nnacheta OP, Wara HS, Aliyu UR (2009) In vitro and in vivo studies membrane stabilization and cytotoxicity of water spinach from ipogi ponds (Nigeria). Int J PharmTech Res 1:474\u2013482","journal-title":"Int J PharmTech Res"},{"key":"10616_CR44","doi-asserted-by":"publisher","first-page":"5396","DOI":"10.1016\/j.bmc.2009.06.053","volume":"17","author":"J Azema","year":"2009","unstructured":"Azema J, Guidetti B, Dewelle J, Le Calve B, Mijatovic T, Korolyov A, Vaysee J, Malet-Martino R, Kiss R (2009) 7-((4-Substituted)piperazin-1-yl) derivatives of ciprofloxacin synthesis and in vitro biological evaluation as potential antitumor agents. Bioorg Med Chem 17:5396\u20135407. https:\/\/doi.org\/10.1016\/j.bmc.2009.06.053","journal-title":"Bioorg Med Chem"},{"key":"10616_CR45","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/jhet.3768","volume":"57","author":"G Kaur","year":"2019","unstructured":"Kaur G, Kaur M, Sharad L, Bansal M (2019) Theoretical molecular predictions and antimicrobial activities of newly synthesized molecular hybrids of norfloxacin and ciprofloxacin. J Heterocyclic Chem 57:225\u2013237. https:\/\/doi.org\/10.1002\/jhet.3768","journal-title":"J Heterocyclic Chem"},{"key":"10616_CR46","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3390\/antibiotics3030244","volume":"3","author":"M Qandil","year":"2014","unstructured":"Qandil M, Al-Zoubi LO, Al-Bakri AG, Amawi HA, Al-Balas QA, Alkatheriand AM, Albekairy AM (2014) Synthesis, antibacterial evaluation and QSAR of \u03b1-substituted-N4- acetamides of ciprofloxacin and norfloxacin. Antibiotics 3:244\u2013269. https:\/\/doi.org\/10.3390\/antibiotics3030244","journal-title":"Antibiotics"},{"key":"10616_CR47","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1002\/jhet.2915","volume":"54","author":"N Nami","year":"2017","unstructured":"Nami N, Tizkar M, Zardost MR (2017) Solvent-free synthesis of 2,6-dihydroxy-9H-purin and pteridine derivatives. J Heterocyclic Chem 54:3696\u20133699. https:\/\/doi.org\/10.1002\/jhet.2915","journal-title":"J Heterocyclic Chem"},{"key":"10616_CR48","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1155\/2012\/762641","volume":"9","author":"HS Milad","year":"2012","unstructured":"Milad HS, Asieh Y, Navabeh N (2012) Synthesis of novel 6-cyano-9-(aryl)-9H-purine derivatives via formamidine intermediates. E-J Chem 9:219\u2013223. https:\/\/doi.org\/10.1155\/2012\/762641","journal-title":"E-J Chem"},{"key":"10616_CR49","doi-asserted-by":"publisher","first-page":"160","DOI":"10.22052\/JNS.2022.01.015","volume":"12","author":"N Nami Chemazi","year":"2022","unstructured":"Nami Chemazi N, Nami N, Sheikh Bostanabad A (2022) Biosynthesis and characterization of Fe3O4\/CaO nanoparticles and investigation of its catalytic property. J Nanostruct 12:160\u2013169. https:\/\/doi.org\/10.22052\/JNS.2022.01.015","journal-title":"J Nanostruct"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-023-10616-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-023-10616-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-023-10616-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T20:54:18Z","timestamp":1744145658000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-023-10616-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10616"],"URL":"https:\/\/doi.org\/10.1007\/s11030-023-10616-8","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,28]]},"assertion":[{"value":"1 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}